The present disclosure relates generally to bifurcated stent grafts, and more particularly to a dividing wall that terminates at a leading edge radius to improve blood flow dynamics.
In some instances, abdominal aortic aneurism repair is accomplished by implanting a bifurcated stent graft that includes a combined flow path portion that spans the aneurism, and a pair of leg portions that are respectively received in the left and right iliac arteries. Although these devices have performed well for many years, researchers have observed at least one major drawback can result in an increased risk of long term complications for a patient. In particular, it is believed that blood flow dynamics, especially in the vicinity of the bifurcation of the stent graft, can cause blood cell damage and blood protein conformational changes that can lead to complications. In most applications, the bifurcation consists of a saddle area where the stent graft portions for the two iliac arteries are joined.
The present disclosure is directed toward one or more of the problems set forth above.
In one aspect, the bifurcated stent graft includes a stent graft body that defines exactly one main body opening and at least two exit openings. The stent graft body includes at least one stent attached to a graft fabric material. The stent graft body includes a dividing wall that divides a combined flow path into a first flow path and a second flow path that each terminate at one of the respective exit openings. The dividing wall includes a thickness profile that terminates at a leading edge radius that extends across a width of the combined flow path.
In another aspect, a method of bifurcating flow with a bifurcated stent graft includes dividing flow from a combined flow path into a first flow path and a second flow path at a leading edge radius that is spaced from a bifurcation by a dividing wall. The flow is transitioned from the leading edge radius to a tapered segment of the wall at a tangent to the leading edge radius.
Referring to all of the FIGS., a bifurcated stent graft 10, such as a stent graft utilized in abdominal aortic aneurism repair, includes a stent graft body 11 that defines exactly one main body opening 12 and at least two exit openings 13, 14. The stent graft body 11 includes at least one stent 15 attached to a graft fabric material 16. In one specific example, the stent 15 is a self expanding stent of a type well known in the art, and the graft fabric material 16 can be any suitable material known in the art. From the outside, bifurcated stent graft 10 may look much like commercially available bifurcated stent grafts that have been known and used with considerable success for years. However, a stent graft body 11 according to the present disclosure includes a dividing wall 20 (120, 220, 320, 420) that divides a combined flow path 17 into a first flow path 18 and a second flow path 19 that each terminate at one of the respective exit openings 13, 14. The dividing wall includes a thickness profile 21 that terminates at a leading edge radius 22 (122, 222, 322, 422) that extends across a width 25 of the combined flow path 17. Thus, the present disclosure teaches dividing the flow destined for the iliac arteries at the leading edge radius 22 (122, 222, 322, 422) of an internal dividing wall 20 (120, 220, 320, 420), rather than at the crotch or bifurcation 37 of the graft 10 as per the prior art.
The thickness profile 21 of the dividing wall 20 can have a variety of confirmations and still fall within the scope of the present disclosure. For instance, thickness profile 21 may include a tapered segment 23 that smoothly transitions into the leading edge radius 22 at a tangent. The tapered segment 23 may begin as a tangent 26 to the leading edge radius 22. Apart from the possible inclusion of a taper segment 23, the thickness profile 21 of the dividing wall 20 may also include a uniform thickness segment 24. In this context, “uniform thickness” means that this segment has no evident taper, but may show some variability due to the underlying materials (e.g. metallic stenting). The dividing wall 20 may be formed at least partially of the same material as the graft fabric material 16 and may stretch between opposite sides of the stent graft body 11, and may or may not include metallic stent reinforcement. The leading edge radius 22 as well as the contiguous tapered segment 23 or uniform thickness segment 24 may be also formed from the graft fabric material 16, and or may also include a formed feature, such as from plastic, to shape the thickness profile 21 in general, and the leading edge radius 22, in particular. The tapered segment 23 may have a length 27 (l) greater than double a radius r of the leading edge radius 22. In two specific examples, shown in
The dividing wall 20 has a height 36 that extends from the bifurcation 37 of the stent graft body 11 to the leading edge radius 22. In the solid line illustrated embodiment of
The present disclosure also contemplates different leading edge shapes across a width 25 of the combined flow path 17. For instance, the solid line illustrated embodiment (
Although
Referring now specifically to
A variety of different structures are considered for the dividing wall 20 (120, 220, 320, 420). Among these, the leading edge radius 22 (122, 222, 322, 422) could be a coated or an un-coated polymer, such as PTFE, or the leading edge radius 22 (122, 222, 322, 422) could be coated with an elastic (soft) layer to reduce cellular stress that might occur when the blood cells impact the leading edge radius 22 (122, 222, 322, 422). This soft coating may have a Young's Modulus from 1-5 MPa, or similar to endothial tissue. A lower Young's Modulus than natural tissue (e.g., 0.1 MPa) may also be desirable. Apart from being soft, the leading edge radius 22 (122, 222, 322, 422) should be smooth to increase the likelihood of laminar blood flow. The dividing wall 20 (120, 220, 320, 420) may use materials similar or commonly used as stent graft fabric material 16 including but not limited to DACRON, esPTFE with urethane, ePTFE, and others known in the art. The surface properties of the taper (if any) and the remaining portions of the dividing wall 20 (120, 220, 320, 420) may be harder than that of the leading edge radius 22 (122, 222, 322, 422). In addition, the remaining portions of dividing wall 20 (120, 220, 320, 420) may be rougher than the leading edge radius 22 (122, 222, 322, 422) for improved blood flow dynamics, possibly finding an analogy in the roughness of a shark skin surface. Overall, the surface properties may be modified by a coating procedures of additional materials such as nanomaterials and/or polymers. On the otherhand, there may be no difference leading edge, wall and taper properties. The dividing wall 20 (120, 220, 320, 420) may be attached on opposite sides to the stent graft body 11 using surgical sutures or any other strategy known in the art. The dividing wall 20 (120, 220, 320, 420) in general, and the leading edge radius 22 (122, 222, 322, 422) in particular could be strengthened with stent frame material (e.g., nitinol, CoCr, stainless steel, etc.) arranged in such a way to allow crimping of the stent graft 10 within a delivery sheath in a conventional manner.
The present disclosure finds potential application in any bifurcated stent graft application. The present disclosure finds more particular applicability to bifurcated stent grafts for use in the blood circulatory system. Finally the present disclosure finds specific application in bifurcated stent grafts of the type used for abdominal aortic aneurism repair.
A bifurcated stent graft 10 according to the present disclosure may be delivered to a treatment site using known delivery devices and techniques. For instance, the bifurcated stent graft 10 might be compressed about a delivery catheter and covered by a retractable sheath, which is withdrawn at the delivery site to allow the stent graft 10 to self expand to the shape shown in
By appropriately choosing the thickness profile 21 of the dividing wall 20 and the radius r of the leading edge radius 22, less sheer stress may be encountered by blood components, potentially leading to less damage to blood cells and the like due to impact at the dividing point. Furthermore, by using an appropriate surface material and shapes, less or no damage may occur to blood components after the bifurcated stent graft 10 is in place. Furthermore, by making the leading edge radius 22 (122, 222, 322, 422) soft like live tissue, less impact damage to blood cells could be expected.
It should be understood that the above description is intended for illustrative purposes only, and is not intended to limit the scope of the present disclosure in any way. Thus, those skilled in the art will appreciate that other aspects of the disclosure can be obtained from a study of the drawings, the disclosure and the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
6039749 | Marin et al. | Mar 2000 | A |
6070589 | Keith et al. | Jun 2000 | A |
6296661 | Davila et al. | Oct 2001 | B1 |
6517570 | Lau et al. | Feb 2003 | B1 |
6695875 | Stelter et al. | Feb 2004 | B2 |
7160318 | Greenberg et al. | Jan 2007 | B2 |
7175652 | Cook et al. | Feb 2007 | B2 |
7232459 | Greenberg et al. | Jun 2007 | B2 |
7335224 | Ohlenschlaeger | Feb 2008 | B2 |
7686842 | Pavcnik et al. | Mar 2010 | B2 |
7722657 | Hartley | May 2010 | B2 |
7914572 | Hartley et al. | Mar 2011 | B2 |
20020042644 | Greenhalgh | Apr 2002 | A1 |
20060229709 | Morris | Oct 2006 | A1 |
20070156229 | Park | Jul 2007 | A1 |
20080015672 | Binford | Jan 2008 | A1 |
20140031920 | Malek | Jan 2014 | A1 |
20150018933 | Yang et al. | Jan 2015 | A1 |
Number | Date | Country |
---|---|---|
1545393 | Jun 2005 | EP |
2005112823 | Dec 2005 | WO |
2006103641 | Oct 2006 | WO |
2010027677 | Mar 2010 | WO |
Entry |
---|
European Patent Office, European Search Report for Application No. 17207478.3, Published Jun. 1, 2018, Munich Germany. |
Number | Date | Country | |
---|---|---|---|
20180214259 A1 | Aug 2018 | US |
Number | Date | Country | |
---|---|---|---|
62452622 | Jan 2017 | US |